MicroRNAs (miRNA) are recognized to be a fundamental class of regulatory molecules operating in plants and animals. A central goal of miRNA biology is to elucidate the genetic program of miRNA function and regulation. Many genes important for miRNA biogenesis and action have been isolated by candidate gene approaches, from biochemical inferences, and by genetic screens in cells and model organisms ([@bib9]; [@bib16]). These approaches have been very successful in discovering key molecules in the miRNA pathway, but they have been less successful in identifying factors downstream of the pathway and regulators of the pathway. We reasoned that downstream factors and regulators of the miRNA pathway would function in multiple processes affecting gene expression and that mutations in these genes would be pleiotropic and thus discarded from most screens. We therefore designed a systematic mutagenesis screen for genes required for miRNA-mediated silencing that included clonal analysis of gene function. The results of the screen, representing 40% of the *Drosophila* genome, are described here.

When a miRNA is transcribed from the genome, the resulting primary or pri-miRNA transcript extends both 5′ and 3′ from the miRNA sequence, and two sequential processing steps trim the transcript into the mature miRNA ([@bib3]). Processing depends on the miRNA sequence folding into a stem-loop structure. The first processing step, which occurs in the nucleus, excises the stem-loop from the remainder of the transcript to create a pre-miRNA product. For most pri-miRNAs, the RNase III enzyme Drosha carries out this cleavage reaction ([@bib35]). Drosha requires a protein cofactor for efficient and precise processing ([@bib24]). In *Drosophila*, the cofactor Pasha contains two dsRBD domains and stably associates with Drosha to form the Microprocessor complex ([@bib18]). However, this is not the only way to produce pre-miRNAs in animals. An alternative pathway uses splicing of transcripts to liberate introns that precisely mimic the structural features of pre-miRNAs. These mirtrons then enter the miRNA processing pathway without the aid of the Microprocessor ([@bib42]; [@bib51]). The second processing step excises the terminal loop from the pre-miRNA stem to create a mature miRNA duplex of approximately 22 basepairs in length. The canonical Dicer RNase III carries out this cleavage reaction in the cytoplasm ([@bib30]). It is aided by the associated activity of a dsRBD-domain protein, Loquacious in *Drosophila* ([@bib22]; [@bib52]).

The mature miRNA duplex is a short-lived entity; it is rapidly unwound when it associates with an Argonaute (Ago) protein ([@bib16]). Unwinding is accompanied by differential strand retention; one strand is retained by the Ago protein while the other strand is lost. Although either strand can become stably associated with Ago proteins, the more commonly associated strand is called the miRNA strand, and the other strand is called the miRNA^\*^ strand ([@bib30]). The Ago-miRNA (miRISC) complex is also associated with the protein GW182 ([@bib39]; [@bib43]; [@bib62]). In *Drosophila*, GW182 associates with the miRNA effector protein Ago1, and functional analysis indicates that GW182 is both necessary and sufficient for miRNA-bound Ago1 to silence gene expression ([@bib4]; [@bib20]).

With few exceptions, miRNA-binding sites in RNA transcripts lie in the 3′ UTR and are usually present in multiple copies ([@bib3]). Most miRNAs bind with mismatches and bulges, although a key feature of recognition involves Watson-Crick base pairing of miRNA nucleotides 2--8, representing the seed region. The mechanisms by which miRISC represses gene expression are complex and involve both protein translation and mRNA stability \[reviewed in [@bib9], [@bib21], and [@bib26]\]. Some studies have found evidence for miRISC-repressed translational initiation whereas other studies have found evidence for repression of post-initiation processes. Currently, there are three competing models for how miRISC represses initiation. One model proposes that miRISC competes with eIF4E for binding to the mRNA 5′ cap structure and thereby blocks 40S subunit recruitment. A second model has proposed that miRISC stimulates deadenylation of the mRNA tail. In this model, translation is repressed because the cap and tail of the deadenylated mRNA are unable to circularize. A third model has proposed that miRISC blocks association of the 60S subunit with the 40S pre-initiation complex.

Transcript stability can also be affected by miRISC ([@bib9]; [@bib21]; [@bib26]). For many miRNA-target interactions, there is a significant reduction in mRNA abundance due to an increase in mRNA degradation. This increased degradation is the result of deadenylation, decapping, and exonucleolytic digestion of the mRNA. A critical question is whether degradation is a consequence of a primary effect on translation. Evidence suggests that degradation can be uncoupled from translation ([@bib26]). At present it is unclear why some targets are degraded and others are not. It has been suggested that the number, type, and position of mismatches in the miRNA/mRNA duplex play an important role in triggering degradation or translation arrest ([@bib1]).

A comprehensive screen for components of the miRNA pathway in *C. elegans* has been performed ([@bib48]). In *Drosophila*, however, systematic mutagenesis screens identifying novel genes in the miRNA pathway have not yet been reported. One screen for components of the miRNA pathway identified alleles of *[Dicer-1](http://flybase.org/reports/FBgn0039016.html)*, *Pasha*, and *Drosha* ([@bib56]), and mutations in *[Dicer-1](http://flybase.org/reports/FBgn0039016.html)*, *Loquacious*, *Ago1*, and *Pasha* have been isolated as a result of targeted mutagenesis ([@bib22]; [@bib29]; [@bib36]; [@bib42]). A comprehensive RNAi screen of the miRNA pathway was performed in S2 cell culture, and positive hits were enriched for genes acting in chromatin remodeling, RNA metabolism, and ubiquitin-proteasome processes ([@bib67]). Together these approaches have implicated ∼100 genes in miRNA function. However, the absence of several known genes from the screens suggest that particular screen methodologies can bias the identification of genes in unpredictable ways and that there are more unidentified genes that act in the *Drosophila* miRNA pathway.

We conducted a large-scale screen of chemical- and transposon-induced mutations to assess the function of 40% of the *Drosophila* genome, including early essential genes and genes with pleiotropic phenotypes. We sought to create allelic series in known genes and to identify new genes associated with miRNA function. We anticipated that this approach would provide an estimate of the total number of genes required for miRNA silencing. Our screen assayed clones of homozygous mutant cells in the compound eye of otherwise heterozygous individuals. We isolated mutations representing 24 genes, 9 of which we identified molecularly, implicating previously identified genes and revealing new factors in silencing regulation.

MATERIALS AND METHODS {#s1}
=====================

Transgenes {#s2}
----------

The 3′UTR of the *[Bearded](http://flybase.org/reports/FBgn0000216.html)* (*[Brd](http://flybase.org/reports/FBgn0000216.html)*) gene plus an additional 134 bp on its 3′ flank was inserted downstream of *eGFP* coding sequence. This was then inserted into the pGMR plasmid to generate *GMR \> eGFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)*. We deleted the vector's mini-*[white](http://flybase.org/reports/FBgn0003996.html)* transformation marker gene so that the transgenic animals would have nonpigmented eyes. This allowed us to detect GFP fluorescence in eyes of transformed animals. A *GMR \> eGFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)* fragment, which had its *miR-4* binding site seeds changed from AGCTTTA to ATAGGGA, was cloned into a pPelican vector with its mini-*[white](http://flybase.org/reports/FBgn0003996.html)* marker gene deleted. This generated *GMR \> eGFP*::*Brdmut*. Transformant lines were generated by standard means and were identified by GFP fluorescence in eyes. The *tub \> eGFP*::*Hid*, *arm \> LacZ*::*E(spl)m8*, and *tub \> eGFP*::*2x(miR-7)* transgenes were described previously ([@bib7]; [@bib32]; [@bib38]).

*Drosophila* stocks {#s3}
-------------------

### For mutagenesis: {#s4}

1.  *yellow (y) white (w)*, *eyFLP* ; *FRT42D* (isogenized second chromosome)

2.  *y w*, *eyFLP* ; *FRT82B* (isogenized third chromosome)

### For screening: {#s5}

1.  *y w*, *eyFLP* ; *FRT42D*, *P{y+}* ; *GMR \> GFP*::*Brd*

2.  *y w*, *eyFLP* ; *GMR \> eGFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)*, *FRT82B ebony (e) / TM3*, *[e](http://flybase.org/reports/FBgn0000527.html)*

### For testcrosses: {#s6}

1.  *y w*, *eyFLP* ; *FRT42D* ; *arm \> LacZ*::*E(spl)m8*

2.  *y w*, *eyFLP* ; *FRT42D*, *arm \> LacZ* ; *tub \> eGFP*::*Hid*

3.  *y w*, *eyFLP* ; *FRT42D*, *GMR \> myr-RFP* ; *GMR \> GFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)*

4.  *y w*, *eyFLP*; *FRT42D*, *arm \> LacZ*; *GMR \> GFP \> GFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)*

5.  *y w*, *eyFLP* ; *GMR \> GFP*::*Brdmut*, *FRT42D*, *GMR \> myr-RFP*

6.  *y w*, *eyFLP* ; *GMR \> eGFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)*, *FRT82B*, *GMR \> myr-RFP / TM6B*

7.  *y w*, *eyFLP* ; *GMR \> eGFP*::*Brdmut* ; *FRT82B*, *GMR \> myr-RFP / TM6B*

8.  *y w*, *eyFLP* ; *arm \> LacZ*::*[Brd](http://flybase.org/reports/FBgn0000216.html)* ; *FRT82B / TM6B*

9.  *y w*, *eyFLP* ; *arm \> LacZ*::*E(spl)m8*, *FRT82B / TM6B*

### For eye phenotype analysis: {#s7}

1.  *y w*, *eyFLP* ; *FRT42D*, *GMR \> Hid / CyO*

2.  *y w*, *eyFLP* ; *FRT82B*, *GMR \> Hid / TM6B*

### For lethal phase analysis: {#s8}

1.  *y w*, *eyFLP*; *FRT82B / TM6B*, *dfd-YFP w+*

Mutagenesis {#s9}
-----------

Three-day-old *y w eyFLP* ; *FRT* males were starved for two hours before feeding overnight on ethyl methanesulfonate (EMS) in 1% sucrose, as described ([@bib36]; [@bib37]). Males were allowed to recover for a few hours, and were then crossed *en masse* to *y w eyFLP* ; *FRT* females carrying the *GMR \> eGFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)* transgene. The female's *FRT* chromosome contained either a dominant (*P{y+}*) or recessive (*[e](http://flybase.org/reports/FBgn0000527.html)*) marker that enabled us to select in subsequent generations for animals who did not carry the marker, and hence, carried a mutagenized *FRT* chromosome. F1 males were examined under a dissecting fluorescence microscope for variegated GFP fluorescence in their compound eyes. Each positive male was backcrossed to *y w eyFLP* ; *FRT* females carrying the *GMR \> eGFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)* transgene. F2 males bearing the genotype *y w*, *eyFLP* ; *FRT*, *mutation* (*^\*^)* / *FRT* were also examined under the microscope for variegated GFP fluorescence. Those males with variegation were crossed to *y w*, *eyFLP* ; *FRT / Balancer* females. F3 animals bearing the genotype *y w*, *eyFLP* ; *FRT*, ^\*^ / *FRT* were assayed for variegated fluorescence, and their *y w*, *eyFLP* ; *FRT*, ^\*^ / *Balancer* sibs were self-crossed to establish balanced stocks. An example of the screen done on 2R is shown in [supporting information](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.002030/-/DC1/002030SI.pdf), [Figure S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.002030/-/DC1/FigureS1.pdf).

To screen lethal piggyBac and P insertional mutations, we utilized two collections from the Drosophila Genetic Resource Center (DGRC, Kyoto, Japan), where insertion mutations had been recombined on *FRT* chromosomes ([@bib12]; [@bib54]). Each line was crossed to *y w*, *eyFLP* ; *FRT* females containing *GMR \> GFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)*. F1 animals were assayed for variegated eye disc fluorescence, and any positive hits were re-assayed.

Mapping {#s10}
-------

We assumed that the mutation causing variegated GFP fluorescence was functionally linked to organismal lethality. Therefore, we mapped the positions of lethal mutations on the mutagenized chromosomes by calculating the frequency of recombination between the lethal mutation and a series of *mini w+*-marked *P*-element insertions located at precise intervals along the chromosome as previously described ([@bib66]). To test our assumption regarding linkage between lethality and GFP expression, viable recombinant progeny from each mapping cross were examined for the GFP phenotype. A strict correlation between viability and lack of a GFP phenotype confirmed this assumption. Once loci had been mapped to a chromosomal interval, we performed fine-scale mapping by crossing mutant lines to flies carrying annotated deficiencies within the chromosomal interval. Complementation/noncomplementation of mutant lethality was used to narrow the loci to as fine a scale as possible. Complementation/noncomplementation of mutant lethality by alleles of known miRNA pathway components was also used to identify new alleles of miRNA pathway component genes isolated during this screen.

Molecular mapping {#s11}
-----------------

*y w*, *eyFLP* ; *FRT*, *^\*^ / Balancer* flies were crossed to the *y w*, *eyFLP* ; *FRT* isogenized parental strain to generate heterozygous flies. Genomic DNA was prepared from these flies for the amplification and sequencing of individual genes. Genomic DNA was prepared by homogenizing adult flies in 50 µl 10 mM Tris-Cl pH 8.2, 1 mM EDTA, 25 mM NaCl, 200 µg/ml proteinase K, and incubating at 37° for 30 min followed by incubation at 95° for 2 min to heat inactivate proteinase K ([@bib23]). For sequencing, both strands of candidate transcription units were sequenced to detect differences between parental and mutagenized DNA sequence.

Complementation analysis {#s12}
------------------------

Mutant autosomes were placed into a background lacking *eyFLP*, and pairwise crosses were made between these mutant lines. F1 heterozygotes were examined for either lethality or changes in GFP fluorescence. Lethality or changes in GFP fluorescence indicated noncomplementing mutants, and they were classified as alleles. When available, we also tested allelic groups for complementation with known alleles of miRNA pathway genes.

Analysis of eye development {#s13}
---------------------------

*y w*, *[ey](http://flybase.org/reports/FBgn0005558.html)*FLP ; *FRT*, *GMR \> Hid / Balancer* animals were crossed to *y w*, *eyFLP* ; *FRT*, *^\*^ / Balancer* animals to generate *y w*, *[ey](http://flybase.org/reports/FBgn0005558.html)*FLP ; *FRT*, *^\*^ / FRT*, *GMR \> Hid* F1 adults. The *GMR \> Hid* transgene drives apoptosis in all eye cells that do not recombine to become homozygous mutant. Remaining mutant eye cells developed into adult eyes that were examined using a Hitachi S-3400N-II scanning electron microscope (SEM). SEM specimens were prepared by freezing adults at −80° for 10 min and mounting them directly onto an aluminum specimen mount with Electrodag 502 conducting graphite paint (Ted Pella Inc.). Images were captured with PC-SEM software and transferred to Quartz PCI software.

Determination of lethal phase {#s14}
-----------------------------

*[w](http://flybase.org/reports/FBgn0003996.html)* ; *FRT*, *^\*^ / Balancer* males were mated to either *[w](http://flybase.org/reports/FBgn0003996.html)* ; *Df / Balancer* or *[w](http://flybase.org/reports/FBgn0003996.html)* ; *FRT*, *^\*^(null) / Balancer* females at 25°. Balancers carried *dfd \> YFP* ([@bib34]) or *twi \> GFP* to enable detection in embryos and larvae. Embryos were collected over 2 hr intervals on egg-laying plates, and those lacking *dfd \> YFP* or *twi \> GFP* fluorescence were selected and transferred to fresh plates. These were incubated at 25°, and the number of living animals was counted daily as well as the stage of development.

*In situ* activity, immunohistochemistry, and Western analysis {#s15}
--------------------------------------------------------------

Homozygous mutant clones were generated using the *FLP-FRT* technique ([@bib64]). Wildtype *FRT* chromosomes carried either myristoylated RFP (*myr-RFP*) driven by the *[GMR](http://flybase.org/reports/FBgn0020433.html)* promoter or *LacZ* driven by the ubiquitous *[armadillo](http://flybase.org/reports/FBgn0000117.html)* (*[arm](http://flybase.org/reports/FBgn0000117.html)*) promoter. These allowed us to mark the mutant cells by virtue of the absence of the marker. Eye discs were fixed in 4% paraformaldehyde on ice. After washing in PBT (PBS + 0.2% Triton X-100), immunostaining was performed ([@bib38]). We used anti-Ago1 (1:200 a gift from M. Siomi, Keio University, Tokyo) and anti-β-Galactosidase (1:750 a gift from G. Beitel, Northwestern University, IL), followed by Alexa 488- or 594-conjugated goat antibodies (1:200; Molecular Probes). Discs were mounted in Vectashield or 90% glycerol and visualized on a Zeiss LSM 510 laser scanning confocal microscope. To detect expression from the *arm \> LacZ*::*E(spl)m8* transgene, we used X-gal activity staining of eye discs as described ([@bib63]). Although this method did not allow us to mark the mutant clones, it was the only way to detect β-Galactosidase from the reporter as immunostaining was not sensitive enough (data not shown). Nevertheless, the strict correlation between mosaic mutant genotype and variegated X-gal staining supports the clonal nature of the staining pattern (N \> 35 discs).

For Western blots, embryos were collected 16 hr after egg laying and were lysed in extraction buffer. After clarification, protein was loaded on an SDS-PAGE gel and blotted to nitrocellulose. Mouse anti-Ago1 (1:2000) and anti-α-tubulin (1:1000) were used to visualize proteins by ECL.

RESULTS {#s16}
=======

Screen design {#s17}
-------------

Mutants were screened for defects in miRNA silencing by assaying a transgene reporter ([Figure 1A](#fig1){ref-type="fig"}). The reporter contains the eGFP coding sequence regulated by two distinct elements. The *[GMR](http://flybase.org/reports/FBgn0020433.html)* transcription promoter limits eGFP expression to the compound eye of *Drosophila*. The 3′UTR from the *[Bearded](http://flybase.org/reports/FBgn0000216.html)* (*[Brd](http://flybase.org/reports/FBgn0000216.html)*) gene renders eGFP expression sensitive to miRNA repression. This UTR has been experimentally demonstrated to contain three binding sites for miR-4/miR-79 and one binding site for miR-7 ([@bib33]). Mutation of the binding sites has been shown to derepress gene expression *in vivo* ([@bib32]). Transgenic animals containing the *GMR \> eGFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)* transgene uniformly exhibited low but detectable green fluorescence in their compound eyes ([Figure 1B](#fig1){ref-type="fig"}).

![Design of the genetic screen. (A) Diagram of the *GMR \> eGFP*::*Brd* transgene reporter. Binding sites for miR-4/-79 (red) and miR-7 (blue) are indicated in the *Brd* 3′UTR. (B) Fluorescence micrograph of the compound eye of an animal expressing one copy of the *GMR \> eGFP*::*Brd* transgene. (C) Genetic scheme of the F1 mosaic screen. \*, mutagenized chromosome; EMS, ethyl methanesulfonate; *eyFLP*, FLP recombinase transgene under *eyeless* promoter control (eye-specific); *FRT*, a FLP recombinase target site transgene (either FRT42D on 2R or FRT82B on 3R) located adjacent to the second and third chromosome centromeres; *w*, *white*; *y*, *yellow*. (D) Scheme of the assay in F1 animals. During the larval phase, FLP catalyzes chromosome crossover during mitosis of eye cells. Homozygous wildtype and mutant daughter cells are generated. Cells in which mitotic crossover has not occurred are heterozygous nonrecombinants. Further cell proliferation results in clones of mutant cells. Fluorescence from the reporter transgene is assayed in adult eyes, and mutant clones with impaired miRNA silencing display higher fluorescence than nonmutant neighboring regions.](437f1){#fig1}

To discover new genes required for miRNA silencing, we used a genetic mosaic strategy in which we examined clones of homozygous mutant eye cells in otherwise heterozygous animals ([Figure 1, C and D](#fig1){ref-type="fig"}). This approach enabled us to recover mutations that otherwise were homozygous lethal to the organism. FLP recombinase was expressed in larval eye cells and catalyzed DNA recombination between FRT sites located on two sister chromosomes ([@bib45]; [@bib60]). The resulting recombined chromosomes segregated during mitosis such that one daughter cell inherited both copies of one sister chromosome, and the other daughter cell inherited copies of the other sister chromosome. Subsequent cell proliferation produced clones of eye cells with the same inherited chromosomes. This approach allowed us to assay mutations that are organismal-lethal but not mutations that are cell-lethal as no clones would be produced from cell-lethal mutants. To identify mutants affecting miRNA silencing, we screened mutant eyes for variegated GFP fluorescence, which was caused by altered *GMR \> eGFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)* expression in homozygous mutant clones.

Because recombination is limited to a single arm of each chromosome, we performed the screen independently on the right arms of chromosomes 2 and 3. These represent 40% of the genome. Our rationale for choosing these arms was that they contained *Ago1*, *Drosha*, *Pasha*, and *[Dicer-1](http://flybase.org/reports/FBgn0039016.html)* genes, and thus, we expected to isolate mutations in these genes if the screen was successful. Mutagenesis was performed in two different ways. We screened a collection of lethal *P*-element and PiggyBac-element insertional mutations that have been mapped to the genome ([@bib54]). We also induced mutations by EMS, as the efficiency of mutagenesis enables screening to apparent saturation. The EMS mutagenesis procedure induces an average of 0.65 lethal mutations per chromosome arm ([@bib46]), and given that we screened a total of 56,000 mutagenized chromosome arms, 29,900 lethal mutations were screened for phenotypes. There are ∼3600 essential *Drosophila* genes ([@bib58]), with roughly 40% (∼1440) on the two chromosome arms that we screened. We expected to observe an average of 21 (29,900/1440) mutations per gene, with at least one mutation in more than 99.9% of all genes.

Overview of screen results {#s18}
--------------------------

We expected that mutations in genes that promoted miRNA-mediated silencing of the eGFP reporter would cause enhanced fluorescence within mitotic eye clones. Over 950 F1 mutants with variegated eye fluorescence were identified from the screen. Of those, only 73 mutants were recovered in the F3 generation as balanced stocks. All of the mutations were homozygous lethal. A number of the mutations that were recovered in the F3 generation had weakly penetrant and expressive phenotypes, and thus we did not consider them for further analysis. The remaining 45 highly penetrant and expressive mutations exhibited robust variegation of the eGFP reporter transgene in mosaic eyes ([Figure 2](#fig2){ref-type="fig"}).

![Mutant phenotypes. Fluorescence from *GMR \> eGFP*::*Brd* in eyes that are completely wildtype (A), or that contain clones that are homozygous mutant for missense alleles in *Pasha* (B), *Dicer-1* (C), and *Ago1* (D), or that are homozygous mutant for nonsense alleles in *Drosha* (E), *Pasha* (F), *Dicer-1* (G), and *Ago1* (H). Alleles are indicated. Note the large patches of brighter fluorescence in missense mutant eyes. The bright patches in nonsense mutant eyes (E--H) are much smaller, and several are highlighted by arrows. The patches in *Dicer-1* and *Ago1* mutants are very small, encompassing one or two ommatidia.](437f2){#fig2}

Complementation tests allowed assignment of the 45 mutations to 24 loci. The mean number of alleles per locus was 1.9, a number far lower than the expected average frequency of 21 predicted by a Poisson distribution. Several factors may have resulted in this discrepancy. The observed 8% frequency of mutant recovery from our F1 mosaic screen is typical when phenotypes are assayed in the adult eye ([@bib36]). The reason for the low recovery has been speculated to be due to mosaicism of mutagenized cells within F1 animals, making recovery of the mutation in subsequent generations difficult ([@bib27]; [@bib28]). Nevertheless, based on the observed allele frequency, we estimate that 85% of loci involved in miRNA silencing were identified in the screen.

Gene identification reveals new pathways {#s19}
----------------------------------------

To begin to define the molecular functions of genes identified in the screen, we mapped representative mutations and molecularly identified nine of the genes ([Table 1](#t1){ref-type="table"}). Four of the identified genes *(Ago1*, *[Dicer-1](http://flybase.org/reports/FBgn0039016.html)*, *Drosha*, and *Pasha*) were previously implicated in miRNA silencing in *Drosophila*. New mutations in these genes were identified by the following critera: (i) they failed to complement various deficiencies or other alleles that uncovered each of these genes, or (ii) a single residue in gene coding sequence was changed in each mutant that either created a nonsense codon or altered an invariant amino acid. New genes were also revealed by our analysis. One gene (*[Dcp1](http://flybase.org/reports/FBgn0034921.html)*) encodes a subunit of the mRNA decapping enzyme, which has been hypothesized as an effector of miRNA silencing ([@bib4]). Three genes (*[grappa](http://flybase.org/reports/FBgn0261972.html)*, *[Bap55](http://flybase.org/reports/FBgn0025716.html)*, and *[domino](http://flybase.org/reports/FBgn0020306.html)*) encode chromatin-remodeling factors. One gene (*[Syndecan](http://flybase.org/reports/FBgn0010415.html)*) encodes a transmembrane coreceptor present on all adherent cells that transduces signals from the extracellular matrix (ECM) to cytoplasm, regulating diverse cell activities ([@bib59]). The extracellular domain contains attachment sites for heparan sulfate polysaccharide chains that mediate interactions with ECM components, heparin-sulfate growth factors, cell adhesion molecules, lipases, chemokines, cytokines, and their receptors ([@bib15]). Thus, a diversity of factors were identified from the genetic screen.

###### Genes and molecular aberrations identified from the screen

  Gene       Allele    Molecular Mutation                                                          Pass Secondary[*^a^*](#t1n1){ref-type="table-fn"}
  ---------- --------- --------------------------------------------------------------------------- ---------------------------------------------------
  Drosha     Q884X     Gln884→Stop ; CAA→TAA                                                       Yes
             Q938X     Gln938→Stop ; CAG→TAG                                                       Yes
             W1123X    Trp1123→Stop ; TGG→TGA                                                      Yes
  Pasha      R59X      Arg59→Stop ; CGA→TGA                                                        Yes
             Q83X      Gln83→Stop ; CAG→TAG                                                        Yes
             P203L     Pro203→Leu ; CCC→CTC                                                        Yes
             Q394X     Gln394→Stop ; CAA→TAA                                                       Yes
             Q579X     Gln579→Stop ; CAG→TAG                                                       Yes
             A13       Unknown                                                                     Yes
  Dicer-1    K43X      Lys43→Stop ; AAG→TAG                                                        Yes
             W94X      Trp94→Stop ; TGG→TGA                                                        Yes
             Q396X     Gln396→Stop ; CAG→TAG                                                       Yes
             Q770X     Gln770→Stop ; CAA→TAA                                                       Yes
             Q991X     Gln991→Stop ; CAA→TAA                                                       Yes
             Q1233X    Gln1233→Stop ; CAG→TAG                                                      Yes
             Q1712X    Gln1712→Stop ; CAA→TAA                                                      Yes
             G2035S    Gly2035→Ser ; GGC→AGC                                                       Yes
  Ago1       Q127X     Gln127→Stop ; CAG→TAG                                                       Yes
             D743N     Asp743→Asn ; GAT→AAT                                                        Yes
             E808K     Glu808→Lys ; GAA→AAA                                                        Yes
             R839X     Arg839→Stop ; CGA→TGA                                                       Yes
             W894X     Trp894→Stop ; TGG→TGA                                                       Yes
             T908M     Thr908→Met ; ACG→ATG                                                        Yes
             R937C     Arg937→Cys ; CGT→TGT                                                        Yes
             J04       Unknown                                                                     Yes
  Bap55      LL05955   2R:13317566(−) ; CDS − V~234~ ▽ K~235~[*^b^*](#t1n2){ref-type="table-fn"}   Yes
  Dcp-1      EY16846   2R:19777750(−) ; 5′UTR − A~34~ ▽ A~35~                                      Yes
  Domino     LL05537   2R:17211471(+) ; intron1 − T~343~ ▽ T~344~                                  Yes
  Grappa     Q210X     Gln210→Stop ; CAG→TAG                                                       Yes
  Syndecan   LL00212   2R:17367838(−) ; 5′UTR − A~149~ ▽ C~150~                                    Yes

Mutations that were tested to affect other reporters as a secondary test for miRNA specificity are indicated.

Insertions of piggyBac or P elements are designated by a ▽ symbol. Insertion point is indicated by the genome sequence position (version FB2011_08, released Sept 2, 2011), the region of the gene, and the base or amino acid sequence position within that gene region.

The other 15 complementation groups that we isolated but did not identify were all generated by EMS mutagenesis. Five of them were tested for their effects on other miRNA sensors, and 4 of them also affect other sensors, suggesting that they are more generally involved in miRNA regulation.

Molecular characterization of mutations in core miRNA pathway genes {#s20}
-------------------------------------------------------------------

We sequenced the mutant protein-coding sequence for each allele of *Ago1*, *[Dicer-1](http://flybase.org/reports/FBgn0039016.html)*, *Drosha*, and *Pasha*, and except for one *Ago1* and *Pasha* allele, each mutant contained a single change in the coding sequence that altered the polypeptide product ([Table 1](#t1){ref-type="table"} and [Figure S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.002030/-/DC1/FigureS2.pdf)). The transcription units of the *Ago1^J04^* and *Pasha^A13^* alleles were completely sequenced, but no mutations were identified. We presume that the responsible mutations might lie in regulatory sequences outside of the units. All genes had at least one mutant allele that contained a nonsense codon, and these alleles we consider presumptive null. In addition, missense mutants were isolated for *[Dicer-1](http://flybase.org/reports/FBgn0039016.html)*, *Pasha*, and *Ago1*. The *Pasha* mutation changes an invariant proline in the WW domain, which is conserved among all known Pasha orthologs. The precise function of the Pasha WW domain remains unknown. The *[Dicer-1](http://flybase.org/reports/FBgn0039016.html)* mutation changes an invariant glycine that is part of the signature motif of RNase III domains, and it is immediately adjacent to a catalytic carboxylate in the second RNase III domain ([@bib41]). It is likely that the change would severely impair catalytic activity of the enzyme. The four *Ago1* mutations altered conserved amino acids within the protein's Piwi domain ([Figure S3](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.002030/-/DC1/FigureS3.pdf)). The Piwi domain of *Drosophila* Ago1 is a RNase H--like endonuclease that cleaves a single phosphodiester bond in the target RNA backbone if it is perfectly complementary to an associated miRNA ([@bib44]). There are two sequence motifs, a GxDV and an RDG motif, within the Piwi domain that are highly conserved in eukaryotic Ago proteins. The two aspartate residues of these motifs are structurally equivalent to two aspartate residues that coordinate a metal ion at the catalytic core of RNase H ([@bib47]; [@bib57]; [@bib65]). A third coordinating carboxylate varies in its position within the active site of RNase H. Studies have determined a histidine residue to be the predominant third residue of Ago necessary for catalysis ([@bib49]). One of the mutations identified in our screen, *Ago1^E808K^*, changes an invariant glutamate residue that is conserved in all sequenced eubacterial and eukaryotic Piwi domains. Importantly, this residue is located 13 residues from the RDG motif, and the homologous residue in crystallized eubacterial Ago proteins is proximate to the active site. Another mutation identified in our screen, *Ago1^R937C^*, changes an arginine residue located only five residues from the coordinating histidine in Ago1, and the homologous residue in a crystallized eukaryotic Ago protein is critical for the 5′ end of guide RNA to bind to the protein ([@bib6]). Mutation of this residue abolishes guide RNA binding, and in *Drosophila* Ago1, abolishes miRNA binding.

In the case of *Ago1*, we observed complex complementation between an existing mutation, *l(2)k08121*, and all of our mapped EMS alleles of *Ago1*. *l(2)k08121* partially or fully complemented the lethality associated with all of our alleles. Moreover, *l(2)k08121* partially complemented the lethality associated with the deficiency *[Df(2R)CX1](http://flybase.org/reports/FBab0022242.html)* that completely uncovers the *Ago1* locus. In contrast, all our new *Ago1* alleles completely failed to complement the deficiency. We ascribe these differences to the hypomorphic nature of *l(2)k08121*. There are four *Ago1* transcripts, and the *l(2)k08121* mutation is caused by a *P*-element insertion in the second intron of the C and D transcripts ([@bib25]; [@bib29]; [@bib50]). We interpret this to mean that the P allele disrupts some but not all *Ago1* mRNA isoforms, and thus the P alleles can complement alleles that affect all isoforms (the deficiency and all of our point mutations).

We used a high-affinity antibody against Ago1 to determine whether the *Ago1* mutants produced protein. We performed Western blots on proteins from 16-hr-old zygotic mutant embryos. Nonsense mutants showed a strong reduction in the level of full-length protein ([Figure 3](#fig3){ref-type="fig"}). We surmise that the remaining full-length protein was maternally loaded from the heterozygous mothers for the following reasons. These mutants showed greater abundance of full-length Ago1 protein if they were harvested at earlier stages of embryonic development, consistent with a gradual decay in protein coming from the eggs (data not shown). Moreover, immunohistochemistry of mosaic eye discs confirmed that the nonsense alleles were protein-null because no fluorescence was detected within mutant cells ([Figure S4](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.002030/-/DC1/FigureS4.pdf)). For two nonsense mutants, smaller Ago1 protein products were detected in the Western blot that were consistent in size with being generated by truncated protein synthesis ([Figure 3](#fig3){ref-type="fig"}). For the four missense mutants, Ago1 abundance and size were normal. These results suggest that the missense mutants make full-length Ago1 protein, but the protein is defective for activity.

![Ago1 protein produced by *Ago1* alleles. Western blots of Ago1 protein from 16-hour zygotic mutant embryos. Wildtype protein was derived from the parental fly line used for mutagenesis. Note the reduced abundance of full-length protein in nonsense mutants. α-tubulin was used as a loading/blotting control.](437f3){#fig3}

Core pathway gene function {#s21}
--------------------------

We examined the effects of mutations on reporter expression in the developing larval eye by identifying the mutant cells using a genetic marker. The *GMR \> eGFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)* reporter was expressed in larval eye cells located posterior to the morphogenetic furrow, a moving wave of cellular differentiation ([Figure 4A](#fig4){ref-type="fig"}). We also examined expression of a different reporter transgene, *GMR \> eGFP*::*Brdmut*, which has its miR-4/-79 binding sites mutated in the *[Brd](http://flybase.org/reports/FBgn0000216.html)* 3′UTR. As expected, the level of eGFP expression in the larval eye was much greater from this mutant transgene when compared with *GMR \> eGFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)* ([Figure 4, B and C](#fig4){ref-type="fig"}).

![Mutant cells derepress the *GMR \> eGFP*::*Brd* reporter in the larval eye. (A) Scheme of third instar larval eye-antennal discs. Posterior to the morphogenetic furrow (MF), cells initiate expression of the reporter gene. (B) A disc from a *GMR \> eGFP*::*Brd* animal. (C) A disc from a *GMR \> eGFP*::*Brdmut* animal. The exposure settings of discs in (B) and (C) are equivalent. (B′, C′) The same discs are shown where the exposure settings are adjusted lower such that the fluorescence from *GMR \> eGFP*::*Brdmut* is not saturating. (D--H) Magnified regions of posterior eye discs from *GMR \> eGFP*::*Brd* animals that contain clones of mutant *Pasha* (D), *Drosha* (E), *Dicer-1* (F), or *Ago1* (G, H) cells. Shown is eGFP fluorescence in green. (D′--H′) The marker expression (purple) is only detected in wildtype and nonrecombinant cells. Cells not expressing the marker are homozygous mutant. (D′′--H′′) The merged images for eGFP and the marker. (I--M) Magnified regions of posterior eye discs from *GMR \> eGFP*::*Brdmut* animals that contain clones of mutant *Pasha* (I), *Drosha* (J), *Dicer-1* (K), or *Ago1* (L, M) cells. Shown is eGFP fluorescence in green. (I′--M′) The marker expression (purple) is only detected in wildtype and nonrecombinant cells. Cells without the marker are homozygous mutant. (I′′--M′′) The merged images for eGFP and marker. Alleles are as indicated.](437f4){#fig4}

We next generated mutant clones that were identified by the lack of expression of a marker transgene. Such marked clones mutant for *Pasha*, *Drosha*, *[Dicer-1](http://flybase.org/reports/FBgn0039016.html)*, and *Ago1* (nonsense or missense) had increased levels of *GMR \> eGFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)* reporter expression ([Figure 4, D--H](#fig4){ref-type="fig"}, [Figure S5](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.002030/-/DC1/FigureS5.pdf), [Figure S6](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.002030/-/DC1/FigureS6.pdf), [Figure S7](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.002030/-/DC1/FigureS7.pdf), [Figure S8](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.002030/-/DC1/FigureS8.pdf), and [Figure S9](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.002030/-/DC1/FigureS9.pdf).). In contrast, mutant clones did not show increased levels of *GMR \> eGFP*::*Brdmut* reporter expression ([Figure 4, I--L](#fig4){ref-type="fig"}), indicating that the repressive effects of these genes on the *GMR \> eGFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)* reporter are mediated through miRNA binding. Interestingly, the mutant clones showed weaker expression from *GMR \> eGFP*::*Brdmut*, suggesting that the four genes activate the *GMR \> eGFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)* reporter in parallel to their direct repression of the reporter mediated by miRNA binding. This activation is likely indirect and mediated through miRNA regulation of transgene repressors.

To determine whether the mutants affected repression of multiple miRNA targets, we assayed the expression of a LacZ reporter transgene that was under control of the *E(spl)m8* 3′UTR. This UTR contains two binding sites for miR-2, which exert strong repression in the developing larval eye ([@bib32]). Mosaic clones mutant for *Ago1*, *[Dicer-1](http://flybase.org/reports/FBgn0039016.html)*, *Drosha*, and *Pasha* showed significant reporter gene derepression when compared with the very weak expression in neighboring wildtype cells ([Figure 5](#fig5){ref-type="fig"}). Thus, the four genes, as expected, are required for repression of multiple targets by multiple miRNAs.

![Mutant cells derepress the *LacZ*::*E(spl)m8* reporter transgene in the larval eye. (A) Wildtype, showing very low level of expression in the eye as seen after X-Gal staining (blue). Expression is strongly induced in eyes with mutant clones in *Pasha* (B), *Drosha* (C), *Dicer-1* (D), and *Ago1* (E). Specific alleles are indicated.](437f5){#fig5}

It has been shown that if target RNAs are perfectly complementary to a miRNA, then Ago proteins can slice (cleave) the target RNA providing they contain a fully functional Piwi domain ([@bib44]). We wondered whether the amino acid substitutions in the Ago1 Piwi domain that we isolated might impair its Slicer activity. Therefore, we expressed an eGFP reporter that contained two perfect binding sites for the miRNA miR-7 in its 3′UTR. When we made mutant clones of *Ago1* missense alleles, we found the reporter was derepressed to the same extent as *Ago1* null alleles ([Figure S10](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.002030/-/DC1/FigureS10.pdf)). Thus, the Piwi mutations affect repression by perfect and imperfect miRNA interactions alike.

MicroRNAs are essential for organismal viability, affecting numerous developmental and physiological pathways. In *Drosophila*, miRNAs are required for germ cell development, cell survival, differentiation, and morphogenesis ([@bib8]). We sought to examine the roles of the four core pathway genes in eye development by generating eyes that were completely homozygous mutant. This was done by using a cell death gene to kill all wildtype and nonrecombinant cells in the developing eye ([@bib60]). The adult compound eyes of such mutants were disrupted to varying degrees. Missense mutations in *Pasha* and *[Dicer-1](http://flybase.org/reports/FBgn0039016.html)* resulted in mispatterned and smaller eyes ([Figure 6, A--C](#fig6){ref-type="fig"}). Three of the *Ago1* missense mutants exhibited very mild mispatterning ([Figure 6D](#fig6){ref-type="fig"}), and the fourth mutant, *Ago1^R937C^*, had a small necrotic eye (data not shown). We also examined various nonsense mutants for eye development phenotypes ([Figure 6, E--H](#fig6){ref-type="fig"}). *Drosha*, *Pasha*, and *[Dicer-1](http://flybase.org/reports/FBgn0039016.html)* nonsense mutants had small mispatterned eyes, whereas for *Ago1* nonsense mutants, the size of the eyes was greatly reduced. In the case of the *Ago1^W894X^* mutant, there was virtually no eye to be found (data not shown).

![Formation of the compound eye requires miRNA pathway genes. Scanning electron micrographs of eyes in which the entire eye tissue is wildtype (A), or homozygous mutant for missense alleles in *Pasha* (B), *Dicer-1* (C), and *Ago1* (D), or homozygous mutant for nonsense alleles in *Drosha* (E), *Pasha* (F), *Dicer-1* (G), and *Ago1* (H). Specific alleles are indicated.](437f6){#fig6}

As mutations in all four genes were homozygous lethal, we determined the developmental stage at which mutant animals succumbed. Zygotic mutant animals were generated from heterozygous parents, so that mutants received a maternal contribution of gene products. These animals were then monitored for life-cycle transitions: embryos hatching into larvae; larvae pupating into pupae; and pupae eclosing into adults. Wildtype heterozygous animals showed robust numbers passing through the monitored life stages ([Figure 7](#fig7){ref-type="fig"} and [Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.002030/-/DC1/TableS1.pdf)). In contrast, mutant animals exhibited lethality at various stages depending upon the gene and allele. *Ago1* nonsense mutants were embryonic lethal ([Figure 7](#fig7){ref-type="fig"} and [Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.002030/-/DC1/TableS1.pdf)), although they showed normal axis patterning (data not shown). Missense *Ago1* alleles exhibited a phenotypic series, with strong to weak severity following: R937C→E808K→T908M→D743N. *Drosha* and *Pasha* mutants were lethal primarily at the pupal stage of life, whereas *[Dicer-1](http://flybase.org/reports/FBgn0039016.html)* mutants were lethal during larval and pupal stages. The early lethality displayed by *Ago1* might be due to less perdurance of maternally supplied Ago1 mRNA and protein. Alternatively, it might be due to functions for *Ago1* not attributed to the other genes, as was suggested from the eye development experiments.

![Lethal phase analysis of pathway mutants. Zygotic mutant embryos were collected and raised at 25°, monitoring the number of animals that survived into the different stages of life cycle: larvae, pupae, and adults. Shown are percentages of animals that hatched into larvae, pupated into pupae, and eclosed into adults for each genotype. The wildtype shown is for *Ago1^T908M^*/+ heterozygotes. Other wildtype genotypes tested (*Ago1^D743N^*/+, *FRT82B/Df*, and *Ago1^Q127X^*/+) show comparable hatching and eclosion frequencies. Various alleles were placed over respective null alleles to exclude the possibility that secondary mutations on each chromosome contributed to the lethal phenotypes. *Dicer-1* and *Pasha* alleles were placed over chromosome deficiencies (*Df*) that uncovered each locus. The number *n* indicates the number of animals analyzed for each genotype.](437f7){#fig7}

RNA decapping is required for miRNA-mediated silencing {#s22}
------------------------------------------------------

One of the mutants isolated from the screen was an insertional mutation in the *[Dcp1](http://flybase.org/reports/FBgn0034921.html)* gene. In the developing larval eye, *[Dcp1](http://flybase.org/reports/FBgn0034921.html)* mutant clones showed strong derepression of *GMR \> eGFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)*, comparable to levels observed with mutations in the core genes ([Figure 8A](#fig8){ref-type="fig"}). Removal of the mRNA 5′ cap structure is catalyzed by the decapping enzyme Dcp2. To be fully active and/or stable, Dcp2 interacts directly with Dcp1, and this interaction is required for decapping *in vivo* and *in vitro* ([@bib14]). We wished to determine whether Dcp2 is also required for the miRNA repression observed in the *Drosophila* eye. Therefore, we obtained an insertional mutant in the *Drosophila Dcp2* gene, and we examined *GMR \> eGFP*::*[Brd](http://flybase.org/reports/FBgn0000216.html)* reporter expression in marked *[Dcp2](http://flybase.org/reports/FBgn0036534.html)* mutant clones ([Figure 8B](#fig8){ref-type="fig"}). The reporter was derepressed in mutant cells, consistent with the effect of *[Dcp1](http://flybase.org/reports/FBgn0034921.html)*.

![Genes encoding mRNA decapping proteins are required for miRNA silencing. (A--A′′) *GMR \> eGFP*::*Brd* expression (green) in *Dcp1* mutant clones marked by the absence of RFP (purple). (B--B′′) *GMR \> eGFP*::*Brd* expression (green) in *Dcp2* mutant clones marked by the absence of RFP (purple). Note strong GFP expression in a subset of mutant cells (arrow). We observe that some cells within a clone are strongly derepressed, whereas other cells do not show derepressed sensor expression. The reasons for this are unclear but might have to do with perdurance of Dcp2 in some mutant cells such that repression is maintained longer than in other sibling cells. (C--C′′) *GMR \> eGFP*::*Brdmut* expression (green) in *Dcp1* mutant clones marked by the absence of RFP (purple). (D--D′′) *GMR \> eGFP*::*Brdmut* expression (green) in *Dcp2* mutant clones marked by the absence of RFP (purple). (E--E′′) *tubulin \> eGFP*::*Hid* expression (green) in *Dcp1* mutant clones marked by the absence of LacZ (purple). (F--H) Expression of *arm \> LacZ*::*E(spl)m8* in a wildtype eye (F), an eye mosaic for *Dcp1* mutant cells (G), and an eye mosaic for *Ago1* mutant cells (H).](437f8){#fig8}

Importantly, the effects of *[Dcp1](http://flybase.org/reports/FBgn0034921.html)* and *[Dcp2](http://flybase.org/reports/FBgn0036534.html)* were dependent upon the presence of miRNA binding sites in the reporter 3′UTR; the *GMR \> eGFP*::*Brdmut* reporter showed no such derepression within *[Dcp1](http://flybase.org/reports/FBgn0034921.html)* and *[Dcp2](http://flybase.org/reports/FBgn0036534.html)* clones ([Figure 8, C and D](#fig8){ref-type="fig"}). *[Dcp1](http://flybase.org/reports/FBgn0034921.html)* clones did not show derepression of the LacZ reporter transgene containing the *E(spl)m8* 3′UTR rather than the *[Brd](http://flybase.org/reports/FBgn0000216.html)* 3′UTR ([Figure 8, F--H](#fig8){ref-type="fig"}). This was a marked discrepancy from the core mutants. One possible explanation is that Dcp1 is highly specific for *[Brd](http://flybase.org/reports/FBgn0000216.html)* repression. To test this possibility, we also looked at a reporter transgene containing the *Hid* 3′UTR. This UTR contains many miRNA binding sites, including sites for the miRNA *[bantam](http://flybase.org/reports/FBgn0262451.html)* ([@bib7]). The *tub \> eGFP*::*Hid* reporter showed derepression within *[Dcp1](http://flybase.org/reports/FBgn0034921.html)* mutant clones ([Figure 8E](#fig8){ref-type="fig"}). Thus, mRNA decapping is required *in vivo* to repress some but not all target genes in a miRNA-dependent manner.

DISCUSSION {#s23}
==========

Here, we have described a systematic screen for factors important for miRNA silencing in *Drosophila*. Genes within 40% of the genome were identified whose loss could perturb silencing but not lead to cell lethality. Applying Poisson analysis to the screen data, we estimate that 28 to 45 genes whose loss might have been detected are present in that 40% of the genome. A genome-wide RNAi screen for genes in the S2 cell miRNA pathway discovered a total of 98 genes required for silencing ([@bib67]), consistent in magnitude with the results from our animal mutagenesis screen.

We observed that *Ago1* mutants exhibited stronger effects on eye development and embryonic viability than mutants in the other core factors. There are several possible explanations. First, it is possible the mutations in the other genes were not null, but we think this unlikely as multiple nonsense alleles for each gene gave similar phenotypes. Second, *Ago1* might encode the only Argonaute protein to mediate miRNA regulation in *Drosophila*, whereas *[Dicer-1](http://flybase.org/reports/FBgn0039016.html)*, *Drosha*, and *Pasha* might be redundant with other genes. For example, Dicer-2 can process pre-miRNAs *in vitro* ([@bib10]) and, therefore, could conceivably contribute to some pre-miRNA processing *in vivo*. Mirtrons are processed by the mRNA splicing machinery and not Microprocessor, and therefore, miRNAs made from mirtrons will function in the absence of *Drosha* and *Pasha*. Third, Ago1 might regulate development using small RNAs that are not miRNAs. For example, a small fraction of endo-siRNAs processed by Dicer-2 are associated with Ago1 ([@bib17]), and some endo-siRNAs might function in eye development. Finally, Ago1 might process certain miRNAs in a manner independent of the other core factors, as has been found for its mammalian ortholog Ago2 ([@bib11]; [@bib13]).

The core mutants displayed another surprising character. The mutants caused repression of the *GMR \> eGFP*::*Brdmut* sensor, which contrasts with the direct role that the wildtype genes play in gene repression. We do not think that this result uncovers a function for the genes in directly activating expression. Rather, it is likely that the mutants derepress the expression of a transcription or translation factor, which in turn inhibits the expression of the sensor.

Three candidates emerging from the screen were chromatin-modifying factors. Grappa is the Dot1 ortholog, a histone H3 K79 methyltransferase that is required for chromatin silencing ([@bib55]). Interestingly, Grappa was also identified from the genome-wide S2 cell screen as a factor weakly required for miRNA-mediated silencing ([@bib67]). Altogether, it would suggest that Grappa regulates diverse RNA-dependent repression in a variety of *Drosophila* cell types. A second factor, Bap55, physically associates with the Brahma chromatin-remodeling complex in *Drosophila* embryo extracts ([@bib2]). Bap55 also associates with Domino (a DNA-dependent ATPase) to form the TIP60 histone acetyltransferase complex ([@bib31]). TIP60 has been shown to be involved in many processes, including both transcriptional activation and repression ([@bib53]). As we identified both *[Bap55](http://flybase.org/reports/FBgn0025716.html)* and *Domino* from our genetic screen, it would suggest that both factors function in miRNA silencing as part of the TIP60 complex, although we cannot yet exclude the possibility that other remodeling complexes might also play a role. [@bib67] also identified *Domino* from their RNAi-based screen, although RNAi of *Domino* led to stronger repression than normal. *[Bap55](http://flybase.org/reports/FBgn0025716.html)* was not identified from their screen. Interestingly, the TIP60 complex has been implicated in dendrite patterning of olfactory projection neurons of *Drosophila* ([@bib61]), a wiring process that is also regulated by the miRNA pathway ([@bib5]).

Genetic evidence that decapping is important for miRNA-mediated repression {#s24}
--------------------------------------------------------------------------

We identified the mRNA decapping genes *[Dcp1](http://flybase.org/reports/FBgn0034921.html)* and *[Dcp2](http://flybase.org/reports/FBgn0036534.html)* as factors required for silencing some but not all miRNA targets. This is the first genetic evidence in animals that decapping is required for miRNA-mediated repression. Earlier studies relying upon S2 cell RNAi depletion and biochemistry had implicated decapping enzymes as destabilizers of miRNA-targeted transcripts ([@bib4]; [@bib19]). Moreover, miRNA targets are frequently localized to P-bodies, cytoplasmic foci rich in decapping proteins ([@bib40]). We found that *[Dcp1](http://flybase.org/reports/FBgn0034921.html)* is not required to silence all reporters we tested. This is consistent with S2 cell knockdowns in which miRNA targets displayed differential sensitivity to loss of decapping ([@bib19]). Targets that were repressed primarily through translation and not mRNA decay were less sensitive to loss of decapping. It was suggested that targets with shorter 3′UTRs (\<500 nts) are less sensitive to decapping enzymes. However, the *E(spl)m8* gene 3′UTR is much longer than the 213 nt *[Brd](http://flybase.org/reports/FBgn0000216.html)* 3′UTR, yet *E(spl)m8* is insensitive to *[Dcp1](http://flybase.org/reports/FBgn0034921.html)* whereas *[Brd](http://flybase.org/reports/FBgn0000216.html)* is quite responsive. The precise features of these miRNA targets that make silencing dependent upon decapping are unknown.

A collection of null mutations in core genes {#s25}
--------------------------------------------

We have provided a rich genetic resource for the further study of the miRNA pathway of *Drosophila*. Null mutations have been isolated in *Drosha*, *Pasha*, *[Dicer-1](http://flybase.org/reports/FBgn0039016.html)*, and *Ago1*. The latter gene in particular has been problematic in terms of generating null mutations. A recent EMS screen failed to detect any *Ago1* mutations ([@bib56]). There are four *Ago1* transcripts: isoforms C and D, with a common promoter, and isoforms A and B, each with unique promoters. *P*-element insertional mutations have been described that are located either in the second intron of C and D transcripts or in the 5′UTR of the B transcript ([@bib25]; [@bib29]; [@bib50]). These mutations appear hypomorphic in nature. The EMS mutations in Ago1 that we recovered are predicted to disrupt the coding sequence of all four transcripts. Some of these mutations are protein-null and will therefore provide useful genetic tools for the *Drosophila* community.
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